Search

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Skin, Lung and Quality of Life II

Session Type: ACR Abstract Submission ACR/ARHP Poster Session B
Tuesday, November 14, 2006
Papers:
1858
Differences in Presentation of Young and Older Systemic Scleroderma (ssc) Patients in Ssc Trials
1859
The Six-Minute Walk Test in Systemic Sclerosis
1860
Validation of Six Minute Walk Testing in Patients with Scleroderma
1861
Predictors of Intrinsic Pulmonary Arterial Hypertension (IPAH) in Patients with Limited Cutaneous Systemic Sclerosis (lcSSc)
1862
Long-term Effects of Bosentan in Pulmonary Arterial Hypertension Related to Connective Tissue Disease (PAH-CTD): The TRUST Study Results
1863
Functional Correlates of Reduction of Digital Ulcers by Bosentan Therapy in Patients with Systemic Sclerosis (SSc)
1864
Detection of Pulmonary Hypertension in Systemic Sclerosis by Exercise Echocardiography
1865
Evaluation of Pulmonary Capillary Volume by the DlCO-DlNO Method in Systemic Sclerosis
1866
Reduced Aerobic Capacity in Systemic Sclerosis (SSc) Patients Without Pulmonary Involvement
1867
Endothelial Dysfunction Precedes Atherosclerosis in Systemic Sclerosis: Relevance for Prevention of Vascular Complications
1868
Plasma Endothelin-1 Levels Correlated with Capillary Dimension Measured by Computer Based Digitized Image in Patients with Systemic Sclerosis
1869
Vascular Regulatory Responses in Secondary Raynaud’s Phenomenon
1870
Whole Finger Iontophoresis - A Possible Future Therapy for Digital Ischaemia in Systemic Sclerosis?
1871
Microvascular Damage Progression and Scoring by Capillaroscopy in Systemic Sclerosis
1872
Scleroderma Renal Crisis: Presentation, Outcome And Risk Factors Based On A Retrospective Multicenter Study Of 50 Patients
1873
Cognitive Impairment in Systemic Sclerosis
1874
Nailfold Capillaroscopic Findings in Systemic Sclerosis Patients
1875
Impairment of Coronary Flow Velocity Reserve After L-Propionylcarnitine Single Intravenous Administration in Patients With Systemic Sclerosis
1876
E/E’ Ratio Assessed by Tissue Doppler Imaging: A Good Index to Predict Left Ventricular Diastolic Dysfunction in Patients with Systemic Sclerosis
1877
Masked Coronary Artery Disease in Systemic Sclerosis
1878
Circulating Anti-U11/U12 Ribonucleoprotein Antibodies in Systemic Sclerosis Are Markers of Severe Lung Fibrosis
1879
Vitamin D, Parathyroid Hormone and Acro-osteolysis in Systemic Sclerosis
1880
Distinction Between Thrombotic Thrombocytopenic Purpura and Scleroderma Renal Crisis in Patients with Systemic Sclerosis; Plasma Von Willebrand Factor Cleaving Protease (adamts13) Activity Measured by a Fluorescence Resonance Energy Transfer Assay
1881
Long Term Follow Up of a Cohort of Patients With Positive Antinuclear Antibodies and Raynaud’s Phenomenon in the Absence of Connective Tissue Disease at Initial Evaluation
1882
Assessment of Hand Vascular Involvement by Magnetic Resonance Angiography in Systemic Sclerosis
1883
Prevalence of Myocardial Dysfunction Assessed by Tissue-Doppler Echocardiography in Patients With Systemic Sclerosis
1884
Serum Levels of Hsp70, a Chaperon for Protecting Against Cellular Injury, are Evaluated in Patients with Systemic Sclerosis: Association with Fibrosis and Vascular Damage
1885
Serum Elevated Levels of Total Antioxidant Power, a Biomarker of Physiological Response to Oxidative Stress, Correlate with Renal Vascular Damage in Patients with Systemic Sclerosis
See more of: ACR Abstract Submission ACR/ARHP Poster Session B

To see other sessions for this day, use the date buttons to the left.